307 related articles for article (PubMed ID: 25680810)
1. The anti-canine distemper virus activities of ex vivo-expanded canine natural killer cells.
Park JY; Shin DJ; Lee SH; Lee JJ; Suh GH; Cho D; Kim SK
Vet Microbiol; 2015 Apr; 176(3-4):239-49. PubMed ID: 25680810
[TBL] [Abstract][Full Text] [Related]
2. Effects of canine distemper virus on natural killer cell activity in dogs.
Ringler SS; Krakowka S
Am J Vet Res; 1985 Aug; 46(8):1781-6. PubMed ID: 4037509
[TBL] [Abstract][Full Text] [Related]
3. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
4. Immune mechanisms against canine distemper. I. Identification of K cell against canine distemper virus infected target cells in vitro.
Ho CK; Babiuk LA
Immunology; 1979 May; 37(1):231-9. PubMed ID: 468299
[TBL] [Abstract][Full Text] [Related]
5. Immune mechanisms against canine distemper. II. Role of antibody in antigen modulation and prevention of intercellular and extracellular spread of canine distemper virus.
Ho CK; Babiuk LA
Immunology; 1979 Dec; 38(4):765-72. PubMed ID: 118114
[TBL] [Abstract][Full Text] [Related]
6. Serological survey of canine distemper virus infection using enzyme-linked immunosorbent assay.
Gemma T; Miyashita N; Shin YS; Okita M; Mori T; Iwatsuki K; Mikami T; Kai C
J Vet Med Sci; 1995 Aug; 57(4):761-3. PubMed ID: 8519915
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiviral efficacy of caffeic acid against canine distemper virus.
Wu ZM; Yu ZJ; Cui ZQ; Peng LY; Li HR; Zhang CL; Shen HQ; Yi PF; Fu BD
Microb Pathog; 2017 Sep; 110():240-244. PubMed ID: 28687324
[TBL] [Abstract][Full Text] [Related]
8. Antiviral efficacy of favipiravir against canine distemper virus infection in vitro.
Xue X; Zhu Y; Yan L; Wong G; Sun P; Zheng X; Xia X
BMC Vet Res; 2019 Sep; 15(1):316. PubMed ID: 31477101
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro.
Lanave G; Cavalli A; Martella V; Fontana T; Losappio R; Tempesta M; Decaro N; Buonavoglia D; Camero M
J Virol Methods; 2017 Oct; 248():207-211. PubMed ID: 28760649
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and application of a Vero cell line stably expressing raccoon dog SLAM, the cellular receptor of canine distemper virus].
Zhao J; Yan R; Zhang H; Zhang L; Hu B; Bai X; Shao X; Chai X; Yan X; Wu W
Wei Sheng Wu Xue Bao; 2012 Dec; 52(12):1515-23. PubMed ID: 23457801
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis.
Alldinger S; Wünschmann A; Baumgärtner W; Voss C; Kremmer E
Acta Neuropathol; 1996 Sep; 92(3):273-80. PubMed ID: 8870829
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of ribavirin against canine distemper virus.
Elia G; Belloli C; Cirone F; Lucente MS; Caruso M; Martella V; Decaro N; Buonavoglia C; Ormas P
Antiviral Res; 2008 Feb; 77(2):108-13. PubMed ID: 17949825
[TBL] [Abstract][Full Text] [Related]
13. The growth profiles of three types of canine distemper virus on Vero cells expressing canine signaling lymphocyte activation molecule.
Lan NT; Yamaguchi R; Kai K; Uchida K; Kato A; Tateyama S
J Vet Med Sci; 2005 May; 67(5):491-5. PubMed ID: 15942133
[TBL] [Abstract][Full Text] [Related]
14. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.
Alves L; Khosravi M; Avila M; Ader-Ebert N; Bringolf F; Zurbriggen A; Vandevelde M; Plattet P
J Virol; 2015 May; 89(10):5724-33. PubMed ID: 25787275
[TBL] [Abstract][Full Text] [Related]
15. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus.
Carvalho OV; Saraiva GL; Ferreira CG; Felix DM; Fietto JL; Bressan GC; Almeida MR; Silva Júnior A
Can J Vet Res; 2014 Oct; 78(4):283-9. PubMed ID: 25355997
[TBL] [Abstract][Full Text] [Related]
16. Effective primary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes.
Lednicky JA; Meehan TP; Kinsel MJ; Dubach J; Hungerford LL; Sarich NA; Witecki KE; Braid MD; Pedrak C; Houde CM
J Virol Methods; 2004 Jun; 118(2):147-57. PubMed ID: 15081610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
Front Immunol; 2018; 9():841. PubMed ID: 29755462
[TBL] [Abstract][Full Text] [Related]
18. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
[TBL] [Abstract][Full Text] [Related]
19. Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.
Sawatsky B; Cattaneo R; von Messling V
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793948
[TBL] [Abstract][Full Text] [Related]
20. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.
Suter SE; Chein MB; von Messling V; Yip B; Cattaneo R; Vernau W; Madewell BR; London CA
Clin Cancer Res; 2005 Feb; 11(4):1579-87. PubMed ID: 15746063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
